Shares of FIGS, Inc. (NYSE: FIGS) surged 6.78% in after-hours trading on Thursday following the release of the company's impressive third-quarter 2025 financial results. The healthcare apparel maker significantly outperformed analyst expectations, demonstrating robust growth across key financial metrics.

FIGS reported quarterly earnings of $0.05 per share, substantially beating the analyst consensus estimate of $0.02 by 212.5%. This represents a remarkable turnaround from the $0.01 loss per share reported in the same period last year. The company's revenue also exceeded expectations, coming in at $151.661 million, a 6.42% beat over the analyst consensus estimate of $142.518 million and an 8.17% increase from the previous year.

The strong financial performance was underpinned by several positive factors. FIGS saw higher orders from both new and existing customers, along with an increased average order value, which rose 5.6% year-over-year to $114. The company's core scrubwear segment showed solid growth, with net revenues reaching $127.0 million, up 8.4% from the same period last year. Additionally, FIGS reported a significant improvement in profitability, with net income surging to $8.7 million compared to a net loss of $1.7 million in the prior-year quarter. The adjusted EBITDA of $18.9 million and margin of 12.4% further underscore the company's operational efficiency. Looking ahead, FIGS provided an optimistic outlook, projecting net revenue growth of about 7.0% for the full year 2025, which likely contributed to investor enthusiasm and the subsequent stock price jump.